Effects of Metformin Combined with Pioglitazone on Body Fat Composition, α and β Cell Function in Patients with Schizophrenia and Type 2 Diabetes Mellitus
YANG Jun-lan, XIONG Rui-cai
Department of medicine, Pengzhou Fourth People's Hospital, Peng Zhou, Sichuan 611933 China
Abstract：【Objective】To analyze the effect of early hypoglycemic agents (metformin and pioglitazone) on the changes in body fat composition, α and β cell function in patients with schizophrenia (SP) and type 2 diabetes mellitus (T2DM).【Methods】A total of 180 patients with SP and T2DM treated in our hospital from January 2015 to June 2016 were selected in the study. Patients were divided into the control group and the observation group by random number table method, with 90 cases in each group. Both groups were given routine basic treatment. The control group was treated with metformin while the observation group was treated with metformin and pioglitazone. Changes in glucose metabolism, body fat composition, α and β cell function before and after treatment were determined and the therapeutic effects were compared between the two groups. The incidence of adverse reactions was statistically analyzed.【Results】After treatment, the fasting blood glucose (FPG), postprandial 2h blood glucose (2hPG) and glycosylated hemoglobin (HbA1c) in the two groups were decreased (P<0.05), but the decrease of 2hPG was more obvious in the observation group than in the control group (P<0.05). After the treatment, the insulin resistance index (HOMA-IR) was decreased and insulin secretion index HOMA-β was increased in both groups (P<0.05). HOMA-β was higher in the observation group than the control group, while HOMA-IR and glucagon levels were lower in the observation group than the control group (P<0.05). After treatment, the total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) were decreased, while triglyceride (TG) and high-density lipoprotein (HDL-C) were increased (P<0.05). The levels of TC and LDL-C in observation group after treatment were lower than those in the control group (P<0.05). After treatment, the body weight and body fat percentage (BF) in the observation group were lower than those in the control group (P<0.05), and there was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).【Conclusion】The body fat percentage is high, function of islet α and β cells is decreased in patients with SP and T2DM. The early treatment with metformin and pioglitazone can improve the body fat composition and optimize the function of islet α and β cells.
杨君兰,熊瑞才. 二甲双胍联合吡格列酮干预对精神分裂症合并2型糖尿病患者体脂成分及α、β细胞功能的影响[J]. 医学临床研究, 2017, 34(10): 1941-1943,1947.
YANG Jun-lan, XIONG Rui-cai. Effects of Metformin Combined with Pioglitazone on Body Fat Composition, α and β Cell Function in Patients with Schizophrenia and Type 2 Diabetes Mellitus. JOURNAL OF CLINICAL RESEARCH, 2017, 34(10): 1941-1943,1947.
2017, Vol. 34 
